Related Experiment Videos
Low-risk palpable breast masses removed using a vacuum-assisted hand-held device
Richard E Fine1, Pat W Whitworth, Julian A Kim
1The Breast Center, Marietta, GA, USA.
American Journal of Surgery
|October 14, 2003
Summary
The Mammotome device safely and effectively removes benign breast masses percutaneously. High patient satisfaction and minimal complications were observed, with most lesions nonpalpable at 6 months.
Area of Science:
- Oncology
- Radiology
- Surgical Innovation
Background:
- Evaluating the Mammotome device for ultrasound-guided percutaneous breast mass removal.
- Assessing safety, efficacy, and patient acceptance of the vacuum-assisted biopsy system.
Purpose of the Study:
- To determine the feasibility and effectiveness of the Mammotome system for benign breast mass removal.
- To evaluate patient satisfaction and procedural outcomes at 6-month follow-up.
Main Methods:
- A multicenter, nonrandomized study involving 216 women with palpable, low-risk breast lesions.
- Utilized 8-gauge and 11-gauge probes for lesion removal based on size (1.5-3.0 cm or <1.5 cm).
- Follow-up assessments at 10 days and 6 months post-biopsy.
Main Results:
- High success rate: 98% of lesions nonpalpable at 6 months; 73% showed no ultrasonographic evidence.
- Excellent patient acceptance: 98% satisfied with incision appearance, 92% would recommend the procedure.
- Complications were generally mild and anticipated.
Conclusions:
- Percutaneous removal of benign breast masses with the Mammotome system is safe and feasible.
- Demonstrated effectiveness in lesion removal, leading to nonpalpability and no need for further procedures.
- High patient satisfaction indicates positive procedural experience and outcomes.